Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Xencor begins Phase II trials of XmAb5871 for IgG4-related disease and SLE

Go Top